Somatic hypermutation is a regulated process that introduces single base changes in variable regions of antibody genes. Hypermutation can have distinct biological roles: it can diversify the immune repertoire or provide the means for production of high affinity antibodies. Hypermutation can also alter the DNA sequence of certain oncogenes, making this pathway important for understanding the mutagenic basis of cancer development. Multiple repair factors are involved in hypermutation.
The specific aims of this proposal are to clarify activities important for hypermutation and elucidate the molecular mechanism of this process. In addition, identification of critical hypermutation molecules and their repair roles will provide new therapeutics that could enhance the efficiency of immunization and decrease the genomic instability associated with cancer. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32GM067482-02
Application #
6779873
Study Section
Special Emphasis Panel (ZRG1-F08 (20))
Program Officer
Portnoy, Matthew
Project Start
2003-08-01
Project End
2005-07-31
Budget Start
2004-08-01
Budget End
2005-07-31
Support Year
2
Fiscal Year
2004
Total Cost
$47,296
Indirect Cost
Name
University of Washington
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Larson, Erik D; Duquette, Michelle L; Cummings, W Jason et al. (2005) MutSalpha binds to and promotes synapsis of transcriptionally activated immunoglobulin switch regions. Curr Biol 15:470-4
Larson, Erik D; Maizels, Nancy (2004) Transcription-coupled mutagenesis by the DNA deaminase AID. Genome Biol 5:211